Dr. Fasano completed his medical training at the University of Naples in Italy, and in 1993 he founded the University of Maryland School of Medicine’s Division of Pediatric Gastroenterology and Nutrition. Ten years later, Dr. Fasano published the groundbreaking study in the Annals of Medicine that established the prevalence rate of celiac disease at one in 133 people in the U.S. In 1996 Dr. Fasano founded the Center for Celiac Research, the first celiac center in the United States, which is currently located at MassGeneral Hospital for Children. Clinical and research work at the Center has helped to identify the new disorder of non-celiac gluten sensitivity as a condition on the spectrum of gluten-related disorders.
Dr. Fasano directs the Mucosal Immunology and Biology Research Center at Massachusetts General and is associate chief for Basic, Clinical and Translational Research. Under his leadership, investigators are studying the molecular mechanisms of autoimmune disorders, including celiac disease, and other gluten-related disorders.

At the Center for Celiac Research and Treatment, Dr. Fasano specializes in the treatment of patients of all ages with gluten-related disorders, including celiac disease, wheat allergy and gluten sensitivity. He treats patients with acute and chronic diarrheal diseases, and treats infants and children who have difficult-to-treat gastrointestinal problems.
He has been named visiting professor of pediatrics at Harvard Medical School. He authored the groundbreaking study in 2003 that established the rate of celiac disease at one in 133 Americans. Widely sought after by national and international media, Dr. Fasano has been featured in hundreds of interviews including outlets such as The New York Times, The Wall Street Journal; National Public Radio; CNN; Bloomberg News, and others.